ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Genetic Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-8Q10673
Home | Market Reports | Science
Global and United States Genetic Vaccine Market Report Forecast 2022 2028
BUY CHAPTERS

Global Genetic Vaccine Market Research Report 2025

Code: QYRE-Auto-8Q10673
Report
July 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Medicago
Pukang Biologic Technology
Johnson & Johnson
Clover Biopharmaceuticals
Suzhou Yuzhibo Biotechnology
Novavax Inc
CureVac
Arcturus Therapeutics
BioNTech
Takeda
Johnson & Johnson

Genetic Vaccine Market Size

The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years.

Genetic Vaccine Market

Genetic Vaccine Market

The global market for Genetic Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Gene vaccine refers to DNA vaccine, the gene encoding exogenous antigen is inserted into the plasmid containing eukaryotic expression system, and then the plasmid is directly introduced into the human or animal body, allowing it to express antigen protein in host cells and induce the immune response of the body.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Genetic Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Vaccine.
The Genetic Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genetic Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Genetic Vaccine Market Report

Report Metric Details
Report Name Genetic Vaccine Market
CAGR 5%
Segment by Type
Segment by Application
  • Human
  • Animal
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals, Plumbline Life Sciences, Medicago, Pukang Biologic Technology, Johnson & Johnson, Clover Biopharmaceuticals, Suzhou Yuzhibo Biotechnology, Novavax, CureVac, Arcturus Therapeutics, BioNTech, Takeda
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Genetic Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Genetic Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Genetic Vaccine Market report?

Ans: The main players in the Genetic Vaccine Market are Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals, Plumbline Life Sciences, Medicago, Pukang Biologic Technology, Johnson & Johnson, Clover Biopharmaceuticals, Suzhou Yuzhibo Biotechnology, Novavax, CureVac, Arcturus Therapeutics, BioNTech, Takeda

What are the Application segmentation covered in the Genetic Vaccine Market report?

Ans: The Applications covered in the Genetic Vaccine Market report are Human, Animal

What are the Type segmentation covered in the Genetic Vaccine Market report?

Ans: The Types covered in the Genetic Vaccine Market report are Recombinant Protein Vaccine, Gene-Based Vaccine

Recommended Reports

Vaccine Markets

Gene Therapies

Vaccine Technologies

1 Genetic Vaccine Market Overview
1.1 Product Definition
1.2 Genetic Vaccine by Type
1.2.1 Global Genetic Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 Genetic Vaccine by Application
1.3.1 Global Genetic Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Human
1.3.3 Animal
1.4 Global Genetic Vaccine Market Size Estimates and Forecasts
1.4.1 Global Genetic Vaccine Revenue 2020-2031
1.4.2 Global Genetic Vaccine Sales 2020-2031
1.4.3 Global Genetic Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Genetic Vaccine Market Competition by Manufacturers
2.1 Global Genetic Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Genetic Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Genetic Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Genetic Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Genetic Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genetic Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Genetic Vaccine, Date of Enter into This Industry
2.8 Global Genetic Vaccine Market Competitive Situation and Trends
2.8.1 Global Genetic Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Genetic Vaccine Players Market Share by Revenue
2.8.3 Global Genetic Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Genetic Vaccine Market Scenario by Region
3.1 Global Genetic Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Genetic Vaccine Sales by Region: 2020-2031
3.2.1 Global Genetic Vaccine Sales by Region: 2020-2025
3.2.2 Global Genetic Vaccine Sales by Region: 2026-2031
3.3 Global Genetic Vaccine Revenue by Region: 2020-2031
3.3.1 Global Genetic Vaccine Revenue by Region: 2020-2025
3.3.2 Global Genetic Vaccine Revenue by Region: 2026-2031
3.4 North America Genetic Vaccine Market Facts & Figures by Country
3.4.1 North America Genetic Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Genetic Vaccine Sales by Country (2020-2031)
3.4.3 North America Genetic Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Genetic Vaccine Market Facts & Figures by Country
3.5.1 Europe Genetic Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Genetic Vaccine Sales by Country (2020-2031)
3.5.3 Europe Genetic Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genetic Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Genetic Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Genetic Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Genetic Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Genetic Vaccine Market Facts & Figures by Country
3.7.1 Latin America Genetic Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Genetic Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Genetic Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genetic Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Genetic Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Genetic Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Genetic Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Genetic Vaccine Sales by Type (2020-2031)
4.1.1 Global Genetic Vaccine Sales by Type (2020-2025)
4.1.2 Global Genetic Vaccine Sales by Type (2026-2031)
4.1.3 Global Genetic Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Genetic Vaccine Revenue by Type (2020-2031)
4.2.1 Global Genetic Vaccine Revenue by Type (2020-2025)
4.2.2 Global Genetic Vaccine Revenue by Type (2026-2031)
4.2.3 Global Genetic Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Genetic Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Genetic Vaccine Sales by Application (2020-2031)
5.1.1 Global Genetic Vaccine Sales by Application (2020-2025)
5.1.2 Global Genetic Vaccine Sales by Application (2026-2031)
5.1.3 Global Genetic Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Genetic Vaccine Revenue by Application (2020-2031)
5.2.1 Global Genetic Vaccine Revenue by Application (2020-2025)
5.2.2 Global Genetic Vaccine Revenue by Application (2026-2031)
5.2.3 Global Genetic Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Genetic Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Genetic Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Genetic Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Genetic Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Zoties
6.4.1 Zoties Company Information
6.4.2 Zoties Description and Business Overview
6.4.3 Zoties Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Zoties Genetic Vaccine Product Portfolio
6.4.5 Zoties Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Company Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Elanco Genetic Vaccine Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Boehringer-Ingelheim
6.6.1 Boehringer-Ingelheim Company Information
6.6.2 Boehringer-Ingelheim Description and Business Overview
6.6.3 Boehringer-Ingelheim Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Boehringer-Ingelheim Genetic Vaccine Product Portfolio
6.6.5 Boehringer-Ingelheim Recent Developments/Updates
6.7 Indian Immunologicals
6.7.1 Indian Immunologicals Company Information
6.7.2 Indian Immunologicals Description and Business Overview
6.7.3 Indian Immunologicals Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Indian Immunologicals Genetic Vaccine Product Portfolio
6.7.5 Indian Immunologicals Recent Developments/Updates
6.8 Plumbline Life Sciences
6.8.1 Plumbline Life Sciences Company Information
6.8.2 Plumbline Life Sciences Description and Business Overview
6.8.3 Plumbline Life Sciences Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Plumbline Life Sciences Genetic Vaccine Product Portfolio
6.8.5 Plumbline Life Sciences Recent Developments/Updates
6.9 Medicago
6.9.1 Medicago Company Information
6.9.2 Medicago Description and Business Overview
6.9.3 Medicago Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Medicago Genetic Vaccine Product Portfolio
6.9.5 Medicago Recent Developments/Updates
6.10 Pukang Biologic Technology
6.10.1 Pukang Biologic Technology Company Information
6.10.2 Pukang Biologic Technology Description and Business Overview
6.10.3 Pukang Biologic Technology Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Pukang Biologic Technology Genetic Vaccine Product Portfolio
6.10.5 Pukang Biologic Technology Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Company Information
6.11.2 Johnson & Johnson Description and Business Overview
6.11.3 Johnson & Johnson Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Johnson & Johnson Genetic Vaccine Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 Clover Biopharmaceuticals
6.12.1 Clover Biopharmaceuticals Company Information
6.12.2 Clover Biopharmaceuticals Description and Business Overview
6.12.3 Clover Biopharmaceuticals Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Clover Biopharmaceuticals Genetic Vaccine Product Portfolio
6.12.5 Clover Biopharmaceuticals Recent Developments/Updates
6.13 Suzhou Yuzhibo Biotechnology
6.13.1 Suzhou Yuzhibo Biotechnology Company Information
6.13.2 Suzhou Yuzhibo Biotechnology Description and Business Overview
6.13.3 Suzhou Yuzhibo Biotechnology Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Suzhou Yuzhibo Biotechnology Genetic Vaccine Product Portfolio
6.13.5 Suzhou Yuzhibo Biotechnology Recent Developments/Updates
6.14 Novavax
6.14.1 Novavax Company Information
6.14.2 Novavax Description and Business Overview
6.14.3 Novavax Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Novavax Genetic Vaccine Product Portfolio
6.14.5 Novavax Recent Developments/Updates
6.15 CureVac
6.15.1 CureVac Company Information
6.15.2 CureVac Description and Business Overview
6.15.3 CureVac Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 CureVac Genetic Vaccine Product Portfolio
6.15.5 CureVac Recent Developments/Updates
6.16 Arcturus Therapeutics
6.16.1 Arcturus Therapeutics Company Information
6.16.2 Arcturus Therapeutics Description and Business Overview
6.16.3 Arcturus Therapeutics Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Arcturus Therapeutics Genetic Vaccine Product Portfolio
6.16.5 Arcturus Therapeutics Recent Developments/Updates
6.17 BioNTech
6.17.1 BioNTech Company Information
6.17.2 BioNTech Description and Business Overview
6.17.3 BioNTech Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 BioNTech Genetic Vaccine Product Portfolio
6.17.5 BioNTech Recent Developments/Updates
6.18 Takeda
6.18.1 Takeda Company Information
6.18.2 Takeda Description and Business Overview
6.18.3 Takeda Genetic Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Takeda Genetic Vaccine Product Portfolio
6.18.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genetic Vaccine Industry Chain Analysis
7.2 Genetic Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genetic Vaccine Production Mode & Process Analysis
7.4 Genetic Vaccine Sales and Marketing
7.4.1 Genetic Vaccine Sales Channels
7.4.2 Genetic Vaccine Distributors
7.5 Genetic Vaccine Customer Analysis
8 Genetic Vaccine Market Dynamics
8.1 Genetic Vaccine Industry Trends
8.2 Genetic Vaccine Market Drivers
8.3 Genetic Vaccine Market Challenges
8.4 Genetic Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Medicago
Pukang Biologic Technology
Johnson & Johnson
Clover Biopharmaceuticals
Suzhou Yuzhibo Biotechnology
Novavax Inc
CureVac
Arcturus Therapeutics
BioNTech
Takeda
Johnson & Johnson
List of Tables
 Table 1. Global Genetic Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Genetic Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Genetic Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Genetic Vaccine Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Genetic Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Genetic Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Genetic Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Genetic Vaccine Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Genetic Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Genetic Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Genetic Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Genetic Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Genetic Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Genetic Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Genetic Vaccine Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Genetic Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Genetic Vaccine Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Genetic Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Genetic Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Genetic Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Genetic Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Genetic Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Genetic Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Genetic Vaccine Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Genetic Vaccine Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Genetic Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Genetic Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Genetic Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Genetic Vaccine Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Genetic Vaccine Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Genetic Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Genetic Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Genetic Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Genetic Vaccine Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Genetic Vaccine Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Genetic Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Genetic Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Genetic Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Genetic Vaccine Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Genetic Vaccine Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Genetic Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Genetic Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Genetic Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Genetic Vaccine Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Genetic Vaccine Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Genetic Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Genetic Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Genetic Vaccine Sales (K Doses) by Type (2020-2025)
 Table 51. Global Genetic Vaccine Sales (K Doses) by Type (2026-2031)
 Table 52. Global Genetic Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Genetic Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Genetic Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Genetic Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Genetic Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Genetic Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Genetic Vaccine Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Genetic Vaccine Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Genetic Vaccine Sales (K Doses) by Application (2020-2025)
 Table 61. Global Genetic Vaccine Sales (K Doses) by Application (2026-2031)
 Table 62. Global Genetic Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Genetic Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Genetic Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Genetic Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Genetic Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Genetic Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Genetic Vaccine Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Genetic Vaccine Price (US$/Dose) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. Merck Genetic Vaccine Product
 Table 74. Merck Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. GSK Genetic Vaccine Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. Sanofi Genetic Vaccine Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Zoties Company Information
 Table 86. Zoties Description and Business Overview
 Table 87. Zoties Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Zoties Genetic Vaccine Product
 Table 89. Zoties Recent Developments/Updates
 Table 90. Elanco Company Information
 Table 91. Elanco Description and Business Overview
 Table 92. Elanco Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 93. Elanco Genetic Vaccine Product
 Table 94. Elanco Recent Developments/Updates
 Table 95. Boehringer-Ingelheim Company Information
 Table 96. Boehringer-Ingelheim Description and Business Overview
 Table 97. Boehringer-Ingelheim Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 98. Boehringer-Ingelheim Genetic Vaccine Product
 Table 99. Boehringer-Ingelheim Recent Developments/Updates
 Table 100. Indian Immunologicals Company Information
 Table 101. Indian Immunologicals Description and Business Overview
 Table 102. Indian Immunologicals Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 103. Indian Immunologicals Genetic Vaccine Product
 Table 104. Indian Immunologicals Recent Developments/Updates
 Table 105. Plumbline Life Sciences Company Information
 Table 106. Plumbline Life Sciences Description and Business Overview
 Table 107. Plumbline Life Sciences Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 108. Plumbline Life Sciences Genetic Vaccine Product
 Table 109. Plumbline Life Sciences Recent Developments/Updates
 Table 110. Medicago Company Information
 Table 111. Medicago Description and Business Overview
 Table 112. Medicago Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 113. Medicago Genetic Vaccine Product
 Table 114. Medicago Recent Developments/Updates
 Table 115. Pukang Biologic Technology Company Information
 Table 116. Pukang Biologic Technology Description and Business Overview
 Table 117. Pukang Biologic Technology Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 118. Pukang Biologic Technology Genetic Vaccine Product
 Table 119. Pukang Biologic Technology Recent Developments/Updates
 Table 120. Johnson & Johnson Company Information
 Table 121. Johnson & Johnson Description and Business Overview
 Table 122. Johnson & Johnson Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 123. Johnson & Johnson Genetic Vaccine Product
 Table 124. Johnson & Johnson Recent Developments/Updates
 Table 125. Clover Biopharmaceuticals Company Information
 Table 126. Clover Biopharmaceuticals Description and Business Overview
 Table 127. Clover Biopharmaceuticals Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 128. Clover Biopharmaceuticals Genetic Vaccine Product
 Table 129. Clover Biopharmaceuticals Recent Developments/Updates
 Table 130. Suzhou Yuzhibo Biotechnology Company Information
 Table 131. Suzhou Yuzhibo Biotechnology Description and Business Overview
 Table 132. Suzhou Yuzhibo Biotechnology Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 133. Suzhou Yuzhibo Biotechnology Genetic Vaccine Product
 Table 134. Suzhou Yuzhibo Biotechnology Recent Developments/Updates
 Table 135. Novavax Company Information
 Table 136. Novavax Description and Business Overview
 Table 137. Novavax Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 138. Novavax Genetic Vaccine Product
 Table 139. Novavax Recent Developments/Updates
 Table 140. CureVac Company Information
 Table 141. CureVac Description and Business Overview
 Table 142. CureVac Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 143. CureVac Genetic Vaccine Product
 Table 144. CureVac Recent Developments/Updates
 Table 145. Arcturus Therapeutics Company Information
 Table 146. Arcturus Therapeutics Description and Business Overview
 Table 147. Arcturus Therapeutics Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 148. Arcturus Therapeutics Genetic Vaccine Product
 Table 149. Arcturus Therapeutics Recent Developments/Updates
 Table 150. BioNTech Company Information
 Table 151. BioNTech Description and Business Overview
 Table 152. BioNTech Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 153. BioNTech Genetic Vaccine Product
 Table 154. BioNTech Recent Developments/Updates
 Table 155. Takeda Company Information
 Table 156. Takeda Description and Business Overview
 Table 157. Takeda Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 158. Takeda Genetic Vaccine Product
 Table 159. Takeda Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Genetic Vaccine Distributors List
 Table 163. Genetic Vaccine Customers List
 Table 164. Genetic Vaccine Market Trends
 Table 165. Genetic Vaccine Market Drivers
 Table 166. Genetic Vaccine Market Challenges
 Table 167. Genetic Vaccine Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Genetic Vaccine
 Figure 2. Global Genetic Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Genetic Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Recombinant Protein Vaccine Product Picture
 Figure 5. Gene-Based Vaccine Product Picture
 Figure 6. Global Genetic Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Genetic Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Human
 Figure 9. Animal
 Figure 10. Global Genetic Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Genetic Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Genetic Vaccine Sales (2020-2031) & (K Doses)
 Figure 13. Global Genetic Vaccine Average Price (US$/Dose) & (2020-2031)
 Figure 14. Genetic Vaccine Report Years Considered
 Figure 15. Genetic Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Genetic Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Genetic Vaccine Players: Market Share by Revenue in Genetic Vaccine in 2024
 Figure 18. Genetic Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Genetic Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Genetic Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Genetic Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Genetic Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Genetic Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Genetic Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Genetic Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Genetic Vaccine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Genetic Vaccine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Genetic Vaccine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Genetic Vaccine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Genetic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Genetic Vaccine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Genetic Vaccine by Type (2020-2031)
 Figure 55. Global Genetic Vaccine Price (US$/Dose) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Genetic Vaccine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Genetic Vaccine by Application (2020-2031)
 Figure 58. Global Genetic Vaccine Price (US$/Dose) by Application (2020-2031)
 Figure 59. Genetic Vaccine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Recombinant Protein Vaccine Market Insights Forecast to 2030
Global DNA Vaccination Market Research Report 2024
Gene Deletion Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Emerging Cancer Vaccines Market Insights Forecast to 2030
Global Genetically Engineered Vaccines for Poultry Market Research Report 2024
Genetically Engineered Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global DNA Vaccines Market Insights Forecast to 2030
Global Poultry Genetic Engineering Vaccine Market Research Report 2024
Genetically Engineered Vaccines for Livestock Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Gun Market Research Report 2024
Global Gene Engineered Subunit Vaccine Market Research Report 2024
Livestock Genetic Engineering Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Chip Market Research Report 2025
HPV Genetically Engineered Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Deleted Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Genetically Engineered Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human DNA Vaccines Market Insights Forecast to 2030
Global Therapeutic Cancer Vaccines Market Research Report 2024
Recombinant DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Ecology Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29H6022
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Robotics Paint Booth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3R7922
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions